Clinical Trial Update: Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye [NA]

View source ↗

Summary

An investigative trial of interferon alpha-2b for ocular melanoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Melanoma

Drugs mentioned

• Interferon-alpha-2b (interferon alfa-2b)

Snippet

Sponsor: Emory University | Conditions: Ocular Melanoma | NA | Status: WITHDRAWN